Bayesian Capital Management’s Axon Enterprise AXON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-468
Closed -$266K 145
2025
Q4
$266K Sell
468
-1,032
-69% -$640K 0.61% 64
2025
Q3
$1.08M Buy
1,500
+475
+46% +$360K 0.22% 150
2025
Q2
$849K Sell
1,025
-3,687
-78% -$2.51M 0.13% 206
2025
Q1
$2.48M Sell
4,712
-3,904
-45% -$2.28M 0.41% 62
2024
Q4
$5.12M Buy
8,616
+4,900
+132% +$2.67M 0.63% 24
2024
Q3
$1.48M Buy
+3,716
New +$1.28M 0.17% 176
2024
Q2
Sell
-7,511
Closed -$2.35M 732
2024
Q1
$2.35M Buy
+7,511
New +$2.09M 0.22% 124
2023
Q2
Sell
-7,700
Closed -$1.73M 794
2023
Q1
$1.73M Buy
+7,700
New +$1.53M 0.21% 130
2022
Q2
Sell
-4,418
Closed -$608K 781
2022
Q1
$608K Sell
4,418
-1,100
-20% -$151K 0.09% 330
2021
Q4
$866K Buy
+5,518
New +$926K 0.27% 111
2021
Q3
Sell
-1,188
Closed -$210K 385
2021
Q2
$210K Buy
+1,188
New +$175K 0.05% 355
2020
Q3
Sell
-10,525
Closed -$1.03M 516
2020
Q2
$1.03M Sell
10,525
-4,100
-28% -$331K 0.23% 123
2020
Q1
$1.03M Buy
+14,625
New +$1.09M 0.22% 125
2018
Q4
Sell
-9,100
Closed -$623K 608
2018
Q3
$623K Sell
9,100
-35,400
-80% -$2.39M 0.1% 277
2018
Q2
$2.81M Buy
44,500
+20,900
+89% +$1.13M 0.63% 23
2018
Q1
$928K Buy
+23,600
New +$736K 0.24% 135
2017
Q3
Sell
-20,275
Closed -$510K 470
2017
Q2
$510K Buy
+20,275
New +$496K 0.19% 181
2017
Q1
Sell
-32,600
Closed -$790K 407
2016
Q4
$790K Buy
+32,600
New +$804K 0.2% 191
2016
Q2
Sell
-14,900
Closed -$292K 399
2016
Q1
$292K Buy
+14,900
New +$256K 0.28% 156

Other funds holding AXON

Bayesian Capital Management's AXON Position: Q1 2026 in Review

Bayesian Capital Management sold out of Axon Enterprise (AXON) in Q1 2026, closing a stake of 468 shares — an estimated $266K sold.

Bayesian Capital Management first reported a position in AXON in Q1 2016 and held it in 19 quarters. The position peaked at $5.12M in Q4 2024. 1,048 funds tracked by Wall St. Rank hold AXON as of Q1 2026.

  • Bayesian Capital Management reported no remaining Axon Enterprise position as of Q1 2026 after selling out during the quarter.
  • Bayesian Capital Management sold 468 Axon Enterprise shares in Q1 2026, an estimated $266K.
  • Bayesian Capital Management first reported a position in Axon Enterprise in Q1 2016 and held it in 19 quarters.
  • Bayesian Capital Management's Axon Enterprise position peaked at $5.12M in Q4 2024.
  • 1,048 funds tracked by Wall St. Rank held Axon Enterprise as of Q1 2026.

Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.